Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 242-901-3 | CAS number: 19234-20-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 Jul - 13 Sep 2013
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well documented study report which meets basic scientific principles
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
- Objective of study:
- other: hydrolysis in rat plasma
- Principles of method if other than guideline:
- Study investigating the in vitro hydrolysis rate of the test substance in rat plasma under physiological conditions
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom
Test material
- Reference substance name:
- 2-(1-methylethoxy)ethyl acetate
- EC Number:
- 242-901-3
- EC Name:
- 2-(1-methylethoxy)ethyl acetate
- Cas Number:
- 19234-20-9
- Molecular formula:
- C7H14O3
- IUPAC Name:
- 2-(propan-2-yloxy)ethyl acetate
- Details on test material:
- - Name of test material (as cited in study report): 2-(1-methylethoxy) ethyl acetate
- Physical state: clear colourless liquid
- Analytical purity: 99.90% (w/w) ester content
- Lot/batch No.: 57033
- Expiration date of the lot/batch: 2014-11-25
- Storage condition of test material: room temperature in the dark
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- other: RCC HAN WISTAR
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST SYSTEM
- Description of the test system: rat (RCC HAN WISTAR) plasma in lithium heparin (Harlan Laboratories, Belton, UK) incubated at 37 ± 0.5 °C.
Administration / exposure
- Route of administration:
- other: the test substance was dissolved in rat plasma and homogenised
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- PRINCIPLE OF THE TEST
The test item was prepared in rat plasma and incubated in the dark in a water bath thermostatically controlled at the test temperature of 37 ± 0.5 °C. The concentration of the test substance was determined as a function of time, using a suitable analytical method (spectrometry or GC-MS analysis).
PERFORMANCE OF THE TEST
SCREENING TEST
A screening test was performed to obtain an estimate of the rate of hydrolysis of the test substance. Therefore, an aliquot (0.0149 g) of the test substance was dissolved in 10 mL rat plasma and shaken to homogenise. The sample was scanned on a Perkin Elmer Spectrum Two Infrared spectrometer using an Attenuated Total Reflectance (ATR) assessory over the wavenumber range of 4000 to 650 cm-1. Sample scans were performed against a background scan of both air and rat plasma.
The sample was scanned against background scans of air and rat plasma after intervals of 1, 2 and 4 h.
DEFINITIVE TESTS
PREPARATION OF TEST SOLUTIONS
For each definitive test, stock solutions were produced by dissolving aliquots of the test item in rat plasma to give a nominal concentration of 1.4 g/L (0.01 M) (see Table 1 under “Any other information on materials and methods incl. tables”). For each test, the stock solution was split into separate glass vessels and sealed.
INCUBATION OF TEST SOLUTIONS
The vessels containing the stock solutions were incubated at 37 ± 0.5 °C. The concentration of the test item in the test solutions was analysed initially and after various incubation times. For each time point, a separate vessel was used for analysis. During test 1, the vessels were allowed to cool to approx. room temperature prior to analysis; for tests 2 to 4, the samples were analysed immediately. - Duration and frequency of treatment / exposure:
- Duration of incubation of the test substance in rat plasma:
Test 1: 0, 1, 2, 3, 4, 24 and 28 h
Test 2: 0, 15, 30, 45 and 60 min
Test 3: 0, 8, 16, 24, 32, 40 and 48 min
Test 4: 0, 8, 16, 24, 32, 40 and 48 min
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1.4 g/L (0.01 M)
- No. of animals per sex per dose / concentration:
- For each test and the respective time points, a separate vessel containing the test item dissolved in rat plasma was used for analysis.
- Control animals:
- other: for GC/MS analysis: matrix blank sample (acetone:rat plasma (9:1 (v/v), filtered) and duplicate standard solutions in acetone:rat plasma (9:1 (v/v), filtered prior to prep. of standards)
- Details on dosing and sampling:
- ANALYSIS OF PARENT SUBSTANCE IN RAT PLASMA
- Principle: the concentrations in the test solutions for each test and the respective time points were analysed using gas chromatography (GC).
- Calibration standard: duplicate standard solutions were prepared at a nominal concentration of 140 mg/mL in acetone:rat plasma (9:1 (v/v), filtered prior to prep. of standards).
Matrix blank: acetone:rat plasma (9:1 (v/v), filtered)
- Sample preparation: an aliquot of each sample vessel removed from incubation was diluted by a factor of 10 with acetone and filtered.
- GC system and conditions:
GC system: Agilent Technologies 6890
Column: DB-5 (30 m x 0.25 mm id x 0.25 µm film)
Injector mode: Split
Split ratio: 5:1
Injection temperature: 275 °C
Oven temperature programme: initial 40 °C for 2 min; rate 20 °C/min; final 280 °C for 5 min
Flow rate: 1.5 mL/min (constant flow)
Detector type: Flame ionisation detector (FID)
FID detector temperature: 275 °C
Injection volume: 1 µL
Retention time of the parent substance: approx. 4 min
ANALYSIS AND IDENTIFICATION OF HYDROLYSIS PRODUCTS IN RAT PLASMA
- Principle: a standard solution, matrix blank as well as initial and 48 min samples from definitive test 3 were analysed using GC-MS (mass spectrometry).
GC system: Agilent Technologies 6890
Column: DB-5 (30 m x 0.25 mm id x 0.25 µm film)
Injector mode: Split
Split ratio: 5:1
Injection temperature: 280 °C
Oven temperature programme: initial 40 °C for 2 min; rate 20 °C/min; final 280 °C for 15 min
Column head pressure: 2.0 psi (constant pressure)
Transfer line temperature: 290 °C
MS quad temperature: 150 °C
MS source temperature: 230 °C
Mass range: scan 35 to 200
Injection volume: 1 µL
Retention time of the parent substance: approx. 6.4 min
Retention time of the hydrolysis product: approx. 4.2 min
A library search was performed on the spectrum obtained for the main hydrolysis product peak. - Statistics:
- Calculations of sample solution concentrations and reaction kinetics are reported under “Any other information on materials and methods incl. tables”.
Results and discussion
- Preliminary studies:
- Screening test: there were no significant changes in the infrared scans of the sample solution over time. Therefore, it was not possible to produce an estimate of the rate of hydrolysis of the test substance.
Main ADME results
- Type:
- other: mean rate constant of hydrolysis in rat plasma (test substance)
- Results:
- 7.83 x 10E-02 min-1, corresponding to a half-life of 8.85 min at 37 ± 0.5 °C
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- not applicable
- Details on distribution in tissues:
- not applicable
- Details on excretion:
- not applicable
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- The identified and expected hydrolysis product of the test item after GC-MS analysis was 2-(1-methylethoxy) ethanol.
Any other information on results incl. tables
CONCENTRATION OF THE SAMPLES AND DATA USED FOR THE CALCULATION OF RATE CONSTANT AND HALF-LIFE
A) DEFINITIVE TEST 1
During test 1, the time points chosen were to widely spaced as the rate of hydrolysis was more rapid than expected, with no test item being detected in any except the initials sample. Therefore, data from test 1 was not sufficient to calculate a result and 3 further tests were performed with the time points taken much more frequently, with dilution and filtration being performed as quickly as possible.
B) DEFINITIVE TEST 2
The following rate constant and half-life for hydrolysis were calculated based on the determined concentrations of the test substance after different incubation time points (see Table 2):
Slope = -9.87 x 10E-02 of linear regression graph
R² = 0.999 of linear regression graph
k = 9.87 x 10E-02 min-1
t1/2 = 7.02 min
Table 2. Concentration of the test substance in rat plasma after different incubation time points
Timepoint (min) |
Concentration (mg/mL) |
Ln C |
0 |
862 |
6.76 |
15 |
176 |
5.17 |
30 |
40.4 |
3.70 |
45 |
10.1 |
2.31 |
Ln C = natural logarithm of the test substance concentration
C) DEFINITIVE TEST 3
The following rate constant and half-life for hydrolysis were calculated based on the determined concentrations of the test substance after different incubation time points (see Table 3):
Slope = -6.80 x 10E-02 of linear regression graph
R² = 0.9902 of linear regression graph
k = 6.8 x 10E-02 min-1
t1/2 = 10.2 min
Table 3. Concentration of the test substance in rat plasma after different incubation time points
Timepoint (min) |
Concentration (mg/mL) |
Ln C |
0 |
1.12E+03 |
7.02 |
8 |
586 |
6.37 |
16 |
324 |
5.78 |
24 |
191 |
5.25 |
32 |
98.0 |
4.58 |
40 |
61.5 |
4.12 |
48 |
46.8 |
3.84 |
Ln C = natural logarithm of the test substance concentration
D) DEFINITIVE TEST 4
The following rate constant and half-life for hydrolysis were calculated based on the determined concentrations of the test substance after different incubation time points (see Table 4):
Slope = -6.81 x 10E-02 of linear regression graph
R² = 0.989 of linear regression graph
k = 6.81 x 10E-02 min-1
t1/2 = 10.2 min
Table 4. Concentration of the test substance in rat plasma after different incubation time points
Timepoint (min) |
Concentration (mg/mL) |
Ln C |
0 |
1.04E+03 |
6.95 |
8 |
461 |
6.13 |
16 |
283 |
5.65 |
24 |
188 |
5.24 |
32 |
112 |
4.72 |
40 |
70.3 |
4.25 |
48 |
30.6 |
3.42 |
Ln C = natural logarithm of the test substance concentration
E) RESULTS FROM TESTS 2, 3 and 4
Mean rate constant (k) of hydrolysis = 7.83 x 10E-02 min-1 (standard deviation: 1.77 x 10E-02)
Mean half-life (t1/2) = 8.85 min
During the tests, the samples were prepared at a nominal concentration of 1400 mg/L. However, analysis of the initial samples gave concentrations from 862 to 1.12E+03 mg/L. This has been attributed to loss of test item through hydrolysis during test preparation. As all times for subsequent time points were relative to the time, the initial samples were treated and the correlation of all plots were good, this was considered to have negligible impact on the results.
VALIDATION OF THE ANALYSIS METHOD (GC)
The linearity of the detector response with respect to concentration of the test item was assessed over the concentration range of 5 to 250 mg/L. This was satisfactory with a correlation coefficient (r) of 1.000 being obtained.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study results
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
